Amanda Oakie

Amanda Oakie

Auto-generated profile, based on publicly available information

Amanda Oakie

McEwen Stem Cell Institute, University Health Network, Toronto, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2013 in Stem Cells and Development
Verified
Journal Article
Closed access
JBJamie Belo
Jamie Belo
MKMansa Krishnamurthy
Mansa Krishnamurthy
AOAmanda Oakie
Amanda Oakie
RWRennian Wang
Rennian Wang
Progenitor expansion during development is a highly regulated process dictating the final organ size, while expansion of specific progenitor populators can adjust the final cellular composition of the organ. Understanding factors involved in these pathways is required to develop cell-based therapies such as β-cell transplantation for conditions such as diabetes mellitus. One versatile factor controlling both processes as well as a network of other proteins involved in pancreatic and duodenal development is the transcription factor SOX9. This review will focus on a comparison of SOX9 function during progenitor expansion and differentiation in the developing pancreas and duodenum with specific focus on endocrine development. During human pancreatic development, SOX9 functions in a dose-dependent manner to regulate epithelial progenitor expansion and endocrine differentiation. SOX9 expression is eventually limited to a subset of ductal and centroacinar cells, hypothesized to be the pancreatic stem cell compartment. Similarly, during duodenal development, SOX9 is expressed in most early epithelial progenitors and becomes gradually restricted to proliferative progenitors in the lower crypts, as well as mature Paneth and enteroendocrine cells indicating some differences in functional roles. However, in both developmental contexts, SOX9 is involved in pathways responsible for cellular proliferation and differentiation, such as Notch and Wnt. With its adaptable and central function in progenitor control, SOX9 represents an attractive target for manipulation for in vitro progenitor expansion and differentiation meriting further investigation.

28 December 2013 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JLJinming Li
Jinming Li
ZFZhi C. Feng
Zhi C. Feng
FYFrances S.-H. Yeung
Frances S.-H. Yeung
MWMelanie R.-M. Wong
Melanie R.-M. Wong
AOAmanda Oakie
Amanda Oakie
RWRennian Wang
Rennian Wang

7 August 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
ZFZhi-Chao Feng
Zhi-Chao Feng
APAlex Popell
Alex Popell
JLJinming Li
Jinming Li
JSJenna Silverstein
Jenna Silverstein
AOAmanda Oakie
Amanda Oakie
RWRennian Wang
Rennian Wang
The receptor tyrosine kinase c-Kit plays an integral role in maintaining β-cell mass and function. Although c-Kit receptor signaling promotes angiogenesis in multiple cell types, its role in islet vasculature is unknown. This study examines the effects of c-Kit–mediated vascular endothelial growth factor isoform A (VEGF-A) and islet vascularization on β-cell function and survival using in vitro cell culture and in vivo mouse models. In cultured INS-1 cells and primary islets, c-Kit regulates VEGF-A expression via the Akt/mammalian target of rapamycin (mTOR) signaling pathway. Juvenile mice with mutated c-Kit (c-KitWv/+) showed impaired islet vasculature and β-cell dysfunction, while restoring c-Kit expression in β-cells of c-KitWv/+ mice rescued islet vascular defects through modulation of the Akt/mTOR/VEGF-A pathway, indicating that c-Kit signaling in β-cells is a required regulator for maintaining normal islet vasculature. Furthermore, β-cell–specific c-Kit overexpression (c-KitβTg) in aged mice showed significantly increased islet vasculature and β-cell function, but, when exposed to a long-term high-fat diet, c-Kit signaling in c-KitβTg mice induced substantial vascular remodeling, which resulted in increased islet inflammatory responses and β-cell apoptosis. These results suggest that c-Kit–mediated VEGF-A action in β-cells plays a pivotal role in maintaining islet vascularization and function.

19 September 2018 in Endocrinology
Verified
Journal Article
Closed access
AOAmanda Oakie
Amanda Oakie
RWRennian Wang
Rennian Wang
Insulin secretion from pancreatic β-cells is initiated through channel-mediated depolarization, cytoskeletal remodeling, and vesicle tethering at the cell membrane, all of which can be regulated through cell surface receptors. Receptor tyrosine kinases (RTKs) promote β-cell development and postnatal signaling to improve β-cell mass and function, yet their activation has also been shown to initiate exocytotic events in β-cells. This review examines the role of RTK signaling in insulin secretion, with a focus on RTKs c-Kit and insulin receptor (IR). Pathways that control insulin release and the potential interplay between c-Kit and IR signaling are discussed, along with clinical implications of RTK therapy on insulin secretion.

15 February 2020 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
PWPhyo Wei Win
Phyo Wei Win
AOAmanda Oakie
Amanda Oakie
JLJinming Li
Jinming Li
RWRennian Wang
Rennian Wang

30 June 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
MTMark Trinder
Mark Trinder
LZLiangyi Zhou
Liangyi Zhou
AOAmanda Oakie
Amanda Oakie
MRMatthew Riopel
Matthew Riopel
RWRennian Wang
Rennian Wang
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Mark Trinder1,2,*, Liangyi Zhou1,3,*, Amanda Oakie1,3, Matthew Riopel1 and Rennian Wang1,2,4 1 Children’s Health Research Institute, London, Ontario, Canada 2 Departments of Physiology & Pharmacology, University of Western Ontario, London, Ontario, Canada 3 Department of Pathology, University of Western Ontario, London, Ontario, Canada 4 Department of Medicine, University of Western Ontario, London, Ontario, Canada * These authors have contributed equally to this study Correspondence to: Rennian Wang, email: // <![CDATA[ mail("rwang","uwo",20,"") // ]]> Keywords: inducible MIP-βIRKO, fetal pancreas, β-cell proliferation, and islet vasculature, Pathology Section Received: October 28, 2015 Accepted: June 12, 2016 Published: June 30, 2016